A potent opiate agonist protects against myocardial stunning during myocardial ischemia and reperfusion in rats

Coronary Artery Disease

Volumn 16, Issue 6, 2005, Pages 407-410

  Song, Woohyuk ^a   Shin, Jinho ^a   Lee, Jaeung ^a   Kim, Hyunjoong ^a   Oh, Dongjoo ^a   Edelberg, Jay M ^a   Wong, S Chiu ^a   Szeto, Hazel ^a   Hong, Mun K ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

Coronary artery disease; Myocardial ischemia; Myocardial stunning; Opiate agonist; Reperfusion

Indexed keywords

2',6' DIMETHYLTYROSINE DEXTRO ARGINYLPHENYLYSINAMIDE; MORPHINE; NATURAL RESISTANCE ASSOCIATED MACROPHAGE PROTEIN 2; OPIATE AGONIST; PLACEBO; TYROSYL DEXTRO ARGINYLPHENYLALANYLLYSINAMIDE; UNCLASSIFIED DRUG;

ANIMAL MODEL; ARTERY LIGATION; ARTICLE; CELL MEMBRANE PERMEABILITY; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DISEASE DURATION; DRUG EFFECT; DRUG HALF LIFE; DRUG MECHANISM; DRUG POTENCY; FRACTIONATION; HEART LEFT VENTRICLE CONTRACTION; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HEART PROTECTION; LEFT ANTERIOR DESCENDING CORONARY ARTERY; NONHUMAN; PRIORITY JOURNAL; RAT; REPERFUSION INJURY; STUNNED HEART MUSCLE; THICKNESS;

ANIMALS; DISEASE MODELS, ANIMAL; ECHOCARDIOGRAPHY; MYOCARDIAL REPERFUSION INJURY; MYOCARDIAL STUNNING; OLIGOPEPTIDES; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, OPIOID; STROKE VOLUME; SYSTOLE; VENTRICULAR FUNCTION, LEFT;

EID: 28944431505     PISSN: 09546928     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019501-200509000-00011     Document Type: Article

References (15)

1. Braunwald E, Kloner RA. The stunned myocardium: prolonged, postischemic ventricular dysfunction. Circulation 1982; 66:1146-1149.
2. Kloner RA, Roberto B, Marban E, Reinlib L, Braunwald E. Medical and cellular implications of stunning, hibernation, and preconditioning: an NHLBI workshop. Circulation 1998; 97:1848-1867.
3. Flaherty JT, Pitt B, Gruber JW, Heuser RR, Rothbaum DA, Burwell LR, et al. Recombinant human superoxide dismutase fails to improve recovery of ventricular function in patients undergoing coronary angioplasty for acute myocardial infarction. Circulation 1994; 89:1982-1991.
4. Schultz JJ, Rose E, Yao Z, Gross GJ. Evidence for involvement of opioid receptors in ischemic preconditioning in rat heart. Am J Physiol 1995; 268:H2157-H2161.
5. 5-enkephalin protects isolated adult rabbit cardiomyocytes via δ opioid receptors. Am J Physiol 1999; 277:H2442-H2450.
6. Schultz JE, Hsu AK, Gross GJ. Morphine mimics the cradioprotective effect of ischemic preconditioning via a glibenclamide-sensitive mechanism in the rat heart. Circ Res 1996; 78:1100-1104.
7. Szeto HH, Lovelace JL, Fridland G, Soong Yi, Fasolo J, Wu D, et al. In vivo pharmacokinetics of selective μ-opioid peptide agonists. J Pharmacol Exp Ther 2001; 298:57-61.
8. Wu D, Soong Y, Zhao GM, Szeto HH. A highly potent peptide analgesic that protects against ischemia-reperfusion-induced myocardial stunning. Am J Physiol Heart Circ Physiol 2002; 283:H783-H791.
9. Zhao K, Zhao GM, Wu D, Soong Y, Birk AV, Schiller PW, et al. Cell-permeable peptide antioxidants targeted to inner mitochondrial membrane inhibit mitochondrial swelling, oxidative cell death and reperfusion injury. J Biol Chem 2004; 279:34682-34690.
10. Schultz JE, Gross GJ. Opioids and cardioprotection. Pharmacol Ther 2001; 89:123-137.
11. Markiewicz W, Finberg JP, Kichtig C. Morphine increases myocardial infarct size in rats. Anesth Analg 1982; 61:843-846.
12. Crompton M, Andreeva L. On the involvement of a mitochondrial pore in reperfusion injury. Basic Res Cardiol 1993; 88:513-523.
13. Zhao ZQ. Oxidative stress-elicited myocardial apoptosis during reperfusion. Curr Opin Pharmacol 2004; 4:159-165.
14. Halestrap AP. The mitochondrial permeability transition - a pore way for the heart to die. J Clin Basic Cardiol 2002; 5:29-41.
15. Shimoyama M, Shimoyama N, Zhao GM, Schiller PW, Szeto HH. Antinociceptive and respiratory effects of intrathecal H-Tyr-D-Arg-Phe-Lys-NH2 (DALDA) and [Dmt1] DALDA. J Pharmacol Exp Ther 2001; 297: 364-371.